文献速递免疫规划

减毒不可转化肺炎链球菌pep27和comD双突变疫苗提供非血清型依赖性保护

Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection.
PubMed 文献 · Vaccine · 2018-11-19

本研究针对肺炎链球菌疫苗的局限性,构建了pep27和comD双突变减毒株(Δpep27ΔcomD),并评估其转化能力、保护效果和安全性。结果显示该双突变株转化能力被成功消除,免疫后显著延长异源攻毒后的生存时间并降低定植水平,且不依赖血清型,包括不可分型菌株NCC1。该疫苗在正常和免疫缺陷小鼠中均高度安全,被认为是预防多种肺炎链球菌感染的高度可行且安全的疫苗。

要点

  • Δpep27ΔcomD双突变株转化能力被成功消除,确保免疫安全性。
  • 免疫后显著延长异源攻毒生存时间并降低定植水平,不依赖血清型。
  • 在正常和免疫缺陷小鼠中均高度安全。

核心结论

  • 肺炎链球菌Δpep27ΔcomD疫苗被认为是预防多种类型肺炎链球菌感染的高度可行且安全的疫苗。

研究设计与样本

  • 本研究构建了pep27和comD双突变减毒株(Δpep27ΔcomD),并测定其转化能力、免疫保护效果及在正常和免疫缺陷小鼠中的安全性。

主要发现

  • Δpep27ΔcomD双突变株的转化能力被成功消除。
  • Δpep27ΔcomD免疫显著延长异源攻毒后的生存时间,并降低定植水平,且不依赖血清型,包括不可分型菌株NCC1。
  • 双突变株在正常和免疫缺陷小鼠中均高度安全。

临床怎么用

  • 该疫苗策略可能为预防多种血清型肺炎链球菌感染提供不依赖血清型的保护,且安全性高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Streptococcus pneumoniae is a well-known pathogenic bacterium with a high mortality rate. Currently, a 23-valent pneumococcal polysaccharide vaccine (PPV23) and protein-conjugate vaccines (PCVs) are available on the market. However, both of these vaccines have limitations; specifically, PPV23 produces weak antibody responses in children younger than 2 years and PCVs only partially protect against secondary infection. Previously, we showed serotype-nonspecific protection by Δpep27 vaccine, but the reversion of Δpep27 to the wild type serotype during immunization cannot be excluded. To ensure the safety of the Δpep27 vaccine, comD, an important protein that activates competence, was inactivated, and the transformability of the double mutant (Δpep27ΔcomD) was determined. The transformation ability of this double mutant was successfully abolished. Δpep27ΔcomD immunization significantly increased the survival time after heterologous challenge(s), and diminished colonization levels independent of serotype, including a non-typeable strain (NCC1). Moreover, the double mutant was found to be highly safe in both normal and immunocompromised mice. In conclusion, this pneumococcal Δpep27ΔcomD vaccine appears to be a highly feasible and safe vaccine to prevent various types of pneumococcal infections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kim SJ, Seon SH, Luong TT, et al. Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection. Vaccine. 2018. PMID: 30467061. doi:10.1016/j.vaccine.2018.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。